Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia
Europe & Central Asia: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 15.7% in 2021. ▼ Falling
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia, 2000–2021
Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.
Analysis
Europe & Central Asia recorded 15.7% for mortality from cvd, cancer, diabetes or crd between exact ages 30 and in 2021. That is the lowest value across all 22 years on record.
The figure is down 0.8% on the previous year and down 16.3% over ten years.
Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia peaked at 23.7% in 2000 and was at its lowest, 15.7%, in 2021.
That places Europe & Central Asia 38th out of 47 groups with data for 2021, putting it in the bottom quarter.
The long-run direction has been consistently falling across the 22 years of available data.
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 23.7% | — |
| 2001 | 23.3% | -1.8% |
| 2002 | 23.2% | -0.4% |
| 2003 | 22.9% | -1.1% |
| 2004 | 22.3% | -2.7% |
| 2005 | 22.2% | -0.4% |
| 2006 | 21.4% | -4.0% |
| 2007 | 20.8% | -2.7% |
| 2008 | 20.4% | -1.8% |
| 2009 | 19.9% | -2.7% |
| 2010 | 19.5% | -2.0% |
| 2011 | 18.8% | -3.3% |
| 2012 | 18.3% | -2.6% |
| 2013 | 17.9% | -2.4% |
| 2014 | 18.0% | +0.4% |
| 2015 | 17.5% | -2.6% |
| 2016 | 17.3% | -1.0% |
| 2017 | 16.9% | -2.4% |
| 2018 | 16.9% | -0.3% |
| 2019 | 16.4% | -2.9% |
| 2020 | 15.9% | -3.0% |
| 2021 | 15.7% | -0.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 22.0% | 19.9% | 23.7% | 10 |
| 2010s | 17.7% | 16.4% | 19.5% | 10 |
| 2020s | 15.8% | 15.7% | 15.9% | 2 |
Countries ranked near Europe & Central Asia
- 36 Uzbekistan 24.6% compare
- 37 Cameroon 24.3% compare
- 38 Myanmar 24.0% compare
- 39 Sierra Leone 23.9% compare
- 40 Belarus 23.8% compare
- 41 Korea, Democratic People's Republic of 23.7% compare
More health data for Europe & Central Asia
- Population ages 45-49, female, annual growth rate 0.9265 % change on previous year (2025)
- Population ages 45-49, male, per capita 0.0339 units per person (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0299 units per person (2025)
- Population ages 45-49, male, annual growth rate 1.04 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0346 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, male, annual growth rate 0.6344 % change on previous year (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
Frequently asked questions
- What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia?
- Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia was 15.7% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
- What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia?
- The highest recorded value was 23.7% in 2000.
- What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia?
- The lowest recorded value was 15.7% in 2021.
- How does Europe & Central Asia rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Europe & Central Asia ranks 38th out of 47 groups with data for 2021.
- Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Europe & Central Asia?
- Over the last ten years it is down 16.3%. The long-run trend across the full record is falling.
- Where does this Europe & Central Asia data come from?
- The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).